Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 6/20 | 0.58 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.53 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | XDH | P47989 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1906438 | 0.92 | TYR (0.50) | TYRGABRA1GABRB2ALOX5POLB | |
| SCHEMBL4446113 | 0.84 | GABRA1 (0.50) | TYRGABRA1GABRB2ALOX5POLB | |
| SCHEMBL9640862 | 0.83 | ESR1 (0.49) | TYRGABRA1GABRB2POLBXDH | |
| SCHEMBL30893166 | 0.83 | GABRA1 (0.70) | TYRGABRA1GABRB2ALOX5POLB | |
| SCHEMBL71514 | 0.83 | GABRA1 (0.70) | TYRGABRA1GABRB2ALOX5POLB | |
| SCHEMBL9296359 | 0.81 | GABRA1 (0.47) | TYRGABRA1GABRB2ALOX5POLB | |
| SCHEMBL1006107 | 0.81 | XDH (0.70) | GABRA1GABRB2ALOX5POLBXDH | |
| SCHEMBL8259600 | 0.81 | GABRA1 (0.52) | GABRA1GABRB2ALOX5POLBXDH | |
| SCHEMBL3749697 | 0.80 | TYR (0.60) | TYRALOX5MEN1MAPTKMT2A | |
| SCHEMBL11115074 | 0.79 | GABRA1 (0.46) | TYRGABRA1GABRB2ALOX5POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024099689-A1 | A PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-05-16 | — | — | WO | claimed |
| CN-114767562-B | Topical skin lightening additives and compositions with amino acids and nicotinamide compounds | 联合利华知识产权控股有限公司 | 2024-05-10 | — | — | CN | claimed |
| EP-3558245-B1 | TOPICAL SKIN LIGHTENING ADDITIVE AND COMPOSITION WITH AMINO ACIDS AND PPAR ACTIVATING FATTY ACIDS | UNILEVER IP HOLDINGS B V (NL) | 2024-02-07 | — | — | EP | claimed |
| CN-115594896-B | Rubber composition, rubber product and application | 北京彤程创展科技有限公司 | 2023-11-21 | — | — | CN | claimed |
| EP-4188309-B1 | COSMETIC MASK FOR IMPROVING APPEARANCE OF SKIN | UNILEVER IP HOLDINGS B V (NL) | 2023-11-01 | — | — | EP | claimed |
| EP-3335694-B1 | MELANOGENESIS INHIBITOR | TAKASAGO PERFUMERY CO LTD (JP) | 2023-09-27 | — | — | EP | claimed |
| US-20230240967-A1 | COSMETIC MASK FOR IMPROVING APPEARANCE OF SKIN | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-08-03 | — | — | US | claimed |
| EP-3708148-B1 | MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR | POLA CHEM IND INC (JP) | 2023-07-19 | — | — | EP | claimed |
| EP-4188309-A1 | COSMETIC MASK FOR IMPROVING APPEARANCE OF SKIN | Unilever IP Holdings B.V. (NL) | 2023-06-07 | — | — | EP | claimed |
| CN-116217754-A | 4-alkyl resorcinol cyclodextrin derivative supermolecule, preparation method thereof and application thereof in preparing cosmetics | 上海贤鼎生物科技有限公司 | 2023-06-06 | — | — | CN | claimed |
| US-20080260878-A1 | Topical; adenosine 5'-monophosphates and salts thereof; arbutins, ellagic acid, 4-alkylresorcinols, linolic acid, tranexamic acid, chamomile extracts, ubiquinones; chloasma, freckles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-10-23 | — | — | US | claimed |
| WO-2007110415-A2 | USE OF DIACETYL TRIMERS AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING THESE COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2007-10-04 | — | — | WO | claimed |
| EP-1806120-A1 | COMPOSITION FOR PREVENTION OR ALLEVIATION OF PIGMENTATION | Otsuka Pharmaceutical Company, Limited (JP) | 2007-07-11 | — | — | EP | claimed |
| US-20060129002-A1 | Process for the synthesis of alkylresorcinols | HONEYWELL INTERNATIONAL INC. | 2006-06-15 | — | — | US | claimed |
| WO-2004052827-A1 | PROCESS FOR THE PREPARATION OF 4-ALKYL RESORCINOL ESTERS | UNILEVER PLC (GB) | 2004-06-24 | — | — | WO | claimed |
| EP-0703780-A4 | USE OF NATURAL PRODUCTS AND RELATED SYNTHETIC COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE | UNIV SYDNEY (AU) | 1998-01-07 | — | — | EP | claimed |
| CN-1124922-A | Use of natural products and related synthetic compounds for the treatment of cardiovascular diseases | UNIV SYDNEY (AU) | 1996-06-19 | — | — | CN | claimed |
| EP-0703780-A1 | USE OF NATURAL PRODUCTS AND RELATED SYNTHETIC COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE | THE UNIVERSITY OF SYDNEY (AU) | 1996-04-03 | — | — | EP | claimed |
| WO-1994028886-A1 | USE OF NATURAL PRODUCTS AND RELATED SYNTHETIC COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE | THE UNIVERSITY OF SYDNEY (AU) | 1994-12-22 | — | — | WO | claimed |
| US-4086281-A | ACID CATALYST | KOPPERS COMPANY, INC. (US) | 1978-04-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060129002-A1 | Process for the synthesis of alkylresorcinols | ACSL4, ZDHHC20, ACSL6 | TYR 2177/4885GABRA1 2595/4885GABRB2 3078/4885 |
| US-20230240967-A1 | COSMETIC MASK FOR IMPROVING APPEARANCE OF SKIN | POT1, TERT, CUTA | TYR 159/4885GABRA1 2253/4885GABRB2 3418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.